NICE IMMUNO-ONCOLOGY APPRAISALS: COMPARISON OF PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL ANALYSIS METHODS AND CRITIQUE

被引：0
|
作者：
Chalmers, K. [1 ]
Pagotto, A. [1 ]
Langford, B. [1 ]
Diamantopoulos, A. [1 ]
Rinciog, C. [1 ]
机构：
[1] Symmetron Ltd, London, England
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA245
引用
收藏
页码：S344 / S344
页数：1
相关论文
共 50 条
  • [21] Progression-Free Survival as a Surrogate Marker of Overall Survival Is It the Good Question?
    Escudier, Bernard
    [J]. CANCER, 2011, 117 (12) : 2586 - 2587
  • [22] A statistical model for the dependence between progression-free survival and overall survival
    Fleischer, Frank
    Gaschler-Markefski, Birgit
    Bluhmki, Erich
    [J]. STATISTICS IN MEDICINE, 2009, 28 (21) : 2669 - 2686
  • [23] Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival
    Broglio, Kristine R.
    Berry, Donald A.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (23) : 1642 - 1649
  • [24] SURVIVAL ANALYSIS METHODS USED IN IMMUNOONCOLOGY NICE APPRAISALS
    Hancock, H.
    Brockbank, J.
    Theodorou, E.
    Brodtkorb, T. H.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S92 - S92
  • [25] Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
    Hess, Lisa M.
    Brnabic, Alan
    Mason, Oksana
    Lee, Pablo
    Barker, Scott
    [J]. JOURNAL OF CANCER, 2019, 10 (16): : 3717 - 3727
  • [26] Progression-free survival (PFS) in oncology: caveat emptor!
    Sarac, Sinan B.
    Ainsworth, Mark A.
    Hovgaard, Doris
    Bjerrum, Ole W.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 124 (03) : 237 - 238
  • [27] Factors impacting progression-free survival (PFS) as a predictor of overall survival (OS)
    Stewart, David J.
    Bosse, Dominick
    Hilton, John Frederick
    Goss, Glenwood D.
    Fung-Kee-Fung, Michael
    Jonker, Derek J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Prognostic Factors for Progression-free Survival and Overall Survival Αfter Recurrence of Glioblastoma
    Zemskova, Oksana
    Yu, Nathan y.
    Leppert, Jan
    Rades, Dirk
    [J]. ANTICANCER RESEARCH, 2024, 44 (07) : 3059 - 3066
  • [29] Impact of Race on Progression-Free Survival and Overall Survival in Patients with Multiple Myeloma
    Wani, Kashmira
    Gutta, Radhika
    Mittal, Aayush
    Jamil, Maria
    Springer, Kylie
    Kuriakose, Philip
    [J]. BLOOD, 2023, 142
  • [30] Relationship Between Progression-Free Survival and Overall Survival Benefit: A Simulation Study
    Zhang, Lijun
    Ko, Chia-Wen
    Tang, Shenghui
    Sridhara, Rajeshwari
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2013, 47 (01) : 95 - 100
12345